Stock Price
1.03
Daily Change
0.01 0.98%
Monthly
31.29%
Yearly
-44.32%
Q2 Forecast
1.00

RedHill Biopharma reported $12.56M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Cara Therapeutics USD 31.54M 6.9M Dec/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 148.02M 59.1M Dec/2025
Cronos Group USD 927.88M 16.21M Mar/2026
RedHill Biopharma USD 12.56M 644K Jun/2025